Seoul National University
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1946-08-22
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.snu.ac.kr
Clinical Trials
102
Active:4
Completed:57
Trial Phases
2 Phases
Phase 3:1
Not Applicable:95
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (96 trials with phase data)• Click on a phase to view related trials
Not Applicable
95 (99.0%)Phase 3
1 (1.0%)Refractory Breathlessness in COPD
Recruiting
- Conditions
- COPD
- First Posted Date
- 2025-09-08
- Last Posted Date
- 2025-09-08
- Lead Sponsor
- Seoul National University
- Target Recruit Count
- 730
- Registration Number
- NCT07160322
- Locations
- 🇰🇷
Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Seoul, South Korea
Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients
Active, not recruiting
- Conditions
- NSCLC, Non Small Cell Lung Cancer
- Interventions
- Drug: Corticosteroids (CS)Drug: Immune Checkpoint Inhibitors
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Seoul National University
- Target Recruit Count
- 2000
- Registration Number
- NCT06751108
- Locations
- 🇰🇷
Seoul National University, Seoul, Korea, Republic of
Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe)
Not Applicable
Recruiting
- Conditions
- Mobile HealthMedication ManagementDrug Labelling
- First Posted Date
- 2024-11-25
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Seoul National University
- Target Recruit Count
- 360
- Registration Number
- NCT06703697
- Locations
- 🇰🇷
Seoul National University, Seoul, Gwanak-gu, Korea, Republic of
Thoracic Sympathetic Ganglion Block With Botulinum Toxin Type A
Not Applicable
Not yet recruiting
- Conditions
- Complex Regional Pain Syndromes
- Interventions
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Seoul National University
- Target Recruit Count
- 78
- Registration Number
- NCT06470581
The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block
Not Applicable
Not yet recruiting
- Conditions
- Complex Regional Pain SyndromesPost Herpetic NeuralgiaChronic PainNeuropathic PainPost Laminectomy Syndrome
- First Posted Date
- 2023-11-14
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Seoul National University
- Target Recruit Count
- 118
- Registration Number
- NCT06130514
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
News
No news found